Keymed Biosciences Inc.
Keymed Biosciences Inc., a biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases. Its lead product candidate is CM310 for the treatment of moderate to severe atopic …
Biotechnology
CN, Chengdu [HQ]
C-Suite · BofD · VPs/SVPs
All the data Keymed Biosciences Inc. presents was sourced from the latest proxy filing.
The proxy statement is the most reliable resource when it comes to compensation breakdowns and other information where an audited is preferred.
Shows the total compensation per mentioned executive and board director.
Each datapoint refers the most recent appearance of the corresponding person.
C-Suite, BofD and VPs/SVPs Beta
The proxy statement is the most reliable resource when it comes to compensation breakdowns and other information where an audited is preferred.
C-Suite and VPs/SVPs
Board of Directors (BofD)
Proxy Sections
Our core belief is in providing transparent validation principles, so here are the document sections we used for retrieving the data over-time:Total Compensation ($)
Add Series
Each datapoint refers the most recent appearance of the corresponding person.